Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot
Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot facility,which will manufacture the company's Oracle and Five-64 catheters.Endosonics will continue to produce its current line of cathetersin Pleasanton.
In other news, Endosonics reported last month that its CardioVascularDynamics (CVD) subsidiary has signed an agreement with the vascularintervention group of Guidant to develop new perfusion angioplastycatheters. Guidant last year received an option for CVD's mechanicalangioplasty catheter (MAC) technology, and last month's agreementexercises that option.
As part of the deal, Guidant granted CVD exclusive rights tomarket Guidant's SmartNeedle products, which use Doppler ultrasound-guidedneedle technology to locate and access arteries and veins in patients.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.